Article
Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes.
Diabetologia - 1 Jul 2021
Segar Matthew W, Patel Kershaw V, Vaduganathan Muthiah, Caughey Melissa C, Jaeger Byron C, Basit Mujeeb, Willett Duwayne, Butler Javed, Sengupta Partho P, Wang Thomas J, McGuire Darren K, Pandey Ambarish
Abstract excerpt
AIMS/HYPOTHESIS: Type 2 diabetes is a heterogeneous disease process with variable trajectories of CVD risk. We aimed to evaluate four phenomapping strategies and their ability to stratify CVD risk in individuals with type 2 diabetes and to identify subgroups who may benefit from specific therapies. METHODS: Participants with type 2 diabetes and free of baseline CVD in the Action to Control Cardiovascular Risk in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
